Clinical Research Directory
Browse clinical research sites, groups, and studies.
Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia
Sponsor: Xiaojun Chen
Summary
To investigate the efficacy of weight management plus levonorgestrel intrauterine system (LNG-IUS) or megestrol acetate (MA) in obese patients with endometrial atypical hyperplasia (EAH) asking for conservative therapy.
Official title: Weight Management Plus Levonorgestrel Intrauterine System or Megestrol Acetate in Endometrial Atypical Hyperplasia: Multiple Single-arm, Prospective and Open-label Clinical Study
Key Details
Gender
FEMALE
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
172
Start Date
2022-06-13
Completion Date
2027-02-28
Last Updated
2025-08-11
Healthy Volunteers
No
Interventions
Intensive Lifestyle Intervention (ILI)
dietary guidance, exercise guidance, lifestyle intervention
Megestrol Acetate 160 MG Oral Tablet
enrolled participants will take Megestrol Acetate 160mg daily
Levonorgestrel-Releasing Intrauterine Contraceptive System (Mirena), 52 Mg
enrolled patients will be treated with LNG-IUS.
Locations (1)
Obstetrics and Gynecology Hospital of Fudan University
Shanghai, China